Reata Pharma (RETA) reported Q2 EPS of ($1.36), $0.75 better than the analyst estimate of ($2.11). Revenue for the quarter came in at $762 thousand versus the consensus estimate of $1.55 million.
Reata Pharma (RETA) reported Q2 EPS of ($1.36), $0.75 better than the analyst estimate of ($2.11). Revenue for the quarter came in at $762 thousand versus the consensus estimate of $1.55 million.